Bio Rad Analysts Recommendations and Consensus

BIO -- USA Stock  

Fiscal Quarter End: December 31, 2019  

The current analyst and expert consensus on Bio Rad is Strong Buy with 0 strong sell and 2 strong buy opinions. The current projected target price consensus is 375.0 with 2 analysts opinions. The most common way Bio Rad Laboratories analysts use to provide recommendation to public is financial statements analysis. Many experts also interview Bio Rad executives and customers to further validate their buy or sell advice. Please note, the number of analysists providing the opinion is not sufficient to provide adequate consensus on Bio Rad. We encourage you to use your own analysis of Bio Rad Laboratories to validate this buy or sell advice. Bio Rad buy or sell recommendation module provides average expert sentiment on the projected Bio Rad Laboratories target price to derive its highest and lowest estimates based on projected price volatility of 35.355. Check also Macroaxis Advice on Bio Rad to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

Bio Rad Target Price Consensus

Number of Opinions2
Lowered Outlook0
Raized Outlook0
Strong Buy
Macroaxis Recommendation   Exposure   Valuation

Bio Rad Target Price Projection

Current Price

Bio Rad Market Quote

Low Price354.23Odds
High Price363.0Odds

358.28

Target Price

Analyst Consensus On Target Price

Low Estimate350.0Odds
High Estimate400.0Odds
Number of Analysts2
Standard Deviation35.355

375.0

Bio Rad Analysit Ratings

Average Consensus

Search macroaxis.com